The Campbell Analysis

Sanofi deepens its AI partnership with CytoReason in a $16M deal, signaling a major shift in using predictive models to accelerate immunology breakthroughs.

Backed by CRISPR pioneers and $16M, a new biotech aims to make personalized gene therapies a scalable reality for millions with rare genetic disorders.

Global Capability Centers are shedding their cost-center image, embracing AI-first models and expanding into new Indian cities to become strategic innovators.

A 70-year-old infrastructure giant launches a new power company, aiming to redefine grid projects with an integrated, civil-first approach.

For over 20 years, Kroll has dominated the global fairness opinion rankings. Discover how the firm's independent advice has shaped over $1T in M&A deals.

Jeegar Shah joins Atomicwork to scale its agentic AI platform, challenging legacy ITSM giants with an AI-first approach built from the ground up.

EF Adventures' new Tour de France tours let fans ride race routes and party with pros, setting a new standard for immersive sports tourism.

A Boston biotech, armed with $62M and a new name, unveils a plan to build a universal model of the cell, aiming to predict and control its behavior.

A major HUD loan sale puts 2,500 occupied homes in the balance, pitting investor profits against the fate of non-borrowing family members.

As its SPAC merger with Churchill Capital IX nears, PlusAI will meet investors at a key conference, showcasing its autonomous trucking tech and strategy.

The healthcare virtual assistant market is set to explode, promising radical efficiency but raising critical questions about privacy, bias, and patient trust.

Guitar Center launches a new podcast hosted by its CEO, a strategic move to engage musicians and redefine its brand amid a major company turnaround.

As PuroClean surpasses 500 locations, its new partnership with KnowHow puts an AI expert in every technician's pocket to ensure consistent quality.

Facing cautious investors, Silicom bets its future on next-gen tech like PQC and Edge. Can its bold growth plans overcome recent financial turbulence?

Forrester names NICE Actimize a leader in APAC fraud solutions, citing its advanced AI as crucial for securing the region's booming digital economy.

A new joint venture between Corewell Health and Quest Diagnostics aims to reshape lab services across Michigan with a new high-tech facility and new efficiencies.

A new health initiative aims to fight chronic disease with personalized nutrition. But can data from your body truly fix a broken food system?

Fresh off a major drug approval, Insmed's upcoming J.P. Morgan talk is under scrutiny as investors eye pipeline updates and acquisition potential.

RPM International's 52nd straight year of dividend hikes cements its 'Dividend King' status. We look at the strategy behind this rare achievement.

Cannara Biotech rockets to #1 in Québec's cannabis market, fueled by a smash-hit vape launch, while also moving to overhaul its corporate governance.